Serum 25-hydroxy vitamin D levels in Turkish adolescent girls with polycystic ovary syndrome and the correlation with clinical/biochemical parameters
Journal of Pediatric and Adolescent Gynecology Aug 09, 2017
Bostanci EI, et al. – The connection between serum 25–hydroxy vitamin D (serum 25(OH) D) levels and metabolic parameters and other characteristics of the polycystic ovary syndrome (PCOS) and non–PCOS adolescents are researched in this study. There was no difference in the level of serum 25(OH) D between PCOS patients and matched controls. Vitamin D deficiency was common among both the patients and the controls. Also, authors did not discover any connection between serum 25(OH) D levels and clinical or metabolic profiles in two groups.
Methods
- For this research, they designed a case–control study.
- In this study, they examined 31 girls with PCOS as characterized with the Rotterdam criteria and 35 girls were non–PCOS controls.
- The serum 25(OH) D level was measured.
- Anthropometric, clinical, endocrine, and metabolic components were determined in both groups.
Results
- The group with PCOS demonstrated no difference in the level of serum 25(OH) D (14.58 ± 6.15 vs 16.02 ± 7.87, p = 0.414).
- And also, no significant correlations were observed between the serum 25(OH) D levels and endocrine or metabolic parameters in either PCOS patients or controls.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries